VS
stockvs
Go to ScreenerHub
LLY

LLY vs NVO

NVO

In the past 12 months, LLY returned +20% while NVO lost 52%.

LLY
LLY

Eli Lilly and Company

$988.79
-4.6%(1M)
Market Cap934.2B
Healthcare
Drug Manufacturers - General
USA
P/E Ratio43.57
ROE97.9%
P/B Ratio33.89
Dividend Yield0.6%
NVO
NVO

Novo Nordisk A/S

$38.58
-21.9%(1M)
Market Cap171.5B
Healthcare
Drug Manufacturers - General
DK
P/E Ratio10.78
ROE61.1%
P/B Ratio5.69
Dividend Yield4.7%
Performance Comparison

Historical returns across multiple timeframes

LLY leads 8/8
LLY

LLY

Eli Lilly and Company

+19.9%

1Y Return

NVO

NVO

Novo Nordisk A/S

-51.9%

1Y Return

LLY
LLY
NVO
NVO

Short Term

1M-6M

LLY
+6.2%

Medium Term

YTD-1Y

LLY
+5.7%

Long Term

3Y-10Y

LLY
+627.4%

Valuation

Compare price multiples and valuation ratios

LLY: 0NVO: 5
MetricLLYNVOWinner
P/E Ratio

Price to earnings ratio

43.5710.78NVO
Forward P/E

Forward price to earnings ratio

0.000.00Tie
P/S Ratio

Price to sales ratio

14.493.57NVO
P/B Ratio

Price to book ratio

33.895.69NVO
P/FCF Ratio

Price to free cash flow ratio

105.2919.66NVO
EV/EBITDA

Enterprise value to EBITDA

34.987.56NVO
PEG Ratio

Price/earnings to growth ratio

0.000.00Tie

Profitability

Compare profit margins and returns on capital

LLY: 4NVO: 2
MetricLLYNVOWinner
Gross Margin

Gross profit margin

83.8%81.0%LLY
Operating Margin

Operating profit margin

45.6%41.3%LLY
Net Margin

Net profit margin

31.7%33.1%NVO
ROE

Return on equity

97.9%61.1%LLY
ROA

Return on assets

18.3%18.9%NVO
ROIC

Return on invested capital

30.2%29.5%LLY

Growth

Compare revenue and earnings growth rates

LLY: 6NVO: 0
MetricLLYNVOWinner
Revenue Growth (YoY)

Year-over-year revenue growth

44.7%2.3%LLY
Revenue Growth (3Y)

3-year revenue CAGR

31.7%18.9%LLY
Revenue Growth (5Y)

5-year revenue CAGR

21.6%18.5%LLY
EPS Growth (YoY)

Year-over-year EPS growth

96.0%1.8%LLY
EPS Growth (3Y)

3-year EPS CAGR

51.7%23.5%LLY
EPS Growth (5Y)

5-year EPS CAGR

28.8%20.7%LLY

Balance Sheet & Risk

Compare financial stability and debt levels

LLY: 3NVO: 2
MetricLLYNVOWinner
Debt/Equity

Debt to equity ratio

1.600.67NVO
Current Ratio

Current assets to current liabilities

1.580.80LLY
Quick Ratio

Quick assets to current liabilities

1.190.57LLY
Interest Coverage

EBIT to interest expense

37.3418.83LLY
Beta

Stock volatility vs market

0.430.27NVO
Summary
LLY wins 3-1

Valuation

NVO

Profitability

LLY

Growth

LLY

Balance Sheet

LLY

NVO is more attractively valued. LLY shows stronger profitability. LLY demonstrates better growth. LLY has a stronger balance sheet.

Related Comparisons
Take Your Analysis Further

Dive deeper into LLY and NVO with Screenerhub. Access advanced screening tools, set up monitoring alerts, and discover more investment opportunities.

Embed This Comparison
Free

Add this comparison widget to your blog or website:

<a href="https://stockvs.app/LLY/vs/NVO" target="_blank" rel="noopener noreferrer" style="display: inline-flex; align-items: center; gap: 8px; padding: 8px 16px; background: linear-gradient(135deg, #3b82f6, #8b5cf6); color: white; text-decoration: none; border-radius: 8px; font-family: system-ui, sans-serif; font-size: 14px; font-weight: 500;">
  <svg width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M18 20V10"/><path d="M12 20V4"/><path d="M6 20v-6"/></svg>
  Compare LLY vs NVO on stockvs.app
</a>